179 related articles for article (PubMed ID: 38566813)
1. Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learning.
Pan J; Zhang J; Lin J; Cai Y; Zhao Z
Front Genet; 2024; 15():1343140. PubMed ID: 38566813
[No Abstract] [Full Text] [Related]
2. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
[No Abstract] [Full Text] [Related]
3. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.
Cheng Z; Huang H; Li M; Liang X; Tan Y; Chen Y
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242427
[TBL] [Abstract][Full Text] [Related]
4. A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer.
Huang H; Chen K; Zhu Y; Hu Z; Wang Y; Chen J; Li Y; Li D; Wei P
J Transl Med; 2024 Feb; 22(1):211. PubMed ID: 38419085
[TBL] [Abstract][Full Text] [Related]
5. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
6. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
[TBL] [Abstract][Full Text] [Related]
7. Characterization of metabolism-associated molecular patterns in prostate cancer.
Yang B; Jiang Y; Yang J; Zhou W; Yang T; Zhang R; Xu J; Guo H
BMC Urol; 2023 Jun; 23(1):104. PubMed ID: 37280589
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer.
Jiang S; Li Z; Dou R; Lin Z; Zhang J; Zhang W; Chen Z; Shen X; Ji J; Qu M; Wang Y; Li M; Gao X
Front Genet; 2022; 13():976850. PubMed ID: 36561322
[No Abstract] [Full Text] [Related]
9. Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing.
Lyu F; Gao X; Ma M; Xie M; Shang S; Ren X; Liu M; Chen J
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370891
[TBL] [Abstract][Full Text] [Related]
10. Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, Lactylation, and Metabolomic Insights in Gastric Cancer through the Integration of Bulk and Single-Cell RNA-Seq Data.
Zhang X; Li Y; Chen Y
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001949
[TBL] [Abstract][Full Text] [Related]
11. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer.
Liu X; Sun K; Yang H; Zou D; Xia L; Lu K; Meng X; Li Y
Heliyon; 2024 Feb; 10(4):e25643. PubMed ID: 38420434
[TBL] [Abstract][Full Text] [Related]
13. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
[TBL] [Abstract][Full Text] [Related]
14. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
Wang S; Bai H; Fei S; Miao B
Biochem Genet; 2023 Oct; ():. PubMed ID: 37898914
[TBL] [Abstract][Full Text] [Related]
15. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.
Ren L; Yang X; Wang W; Lin H; Huang G; Liu Z; Pan J; Mao X
Front Genet; 2023; 14():1096783. PubMed ID: 36911392
[No Abstract] [Full Text] [Related]
16. A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients.
Xiao X; Li J; Wan S; Wu M; Li Z; Tian J; Mi J
Front Genet; 2022; 13():1006151. PubMed ID: 36386841
[No Abstract] [Full Text] [Related]
17. Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response.
Su H; Chen Y; Lin F; Li W; Gu X; Zeng W; Liu D; Li M; Zhong S; Chen Q; Chen Q
Front Oncol; 2023; 13():1325452. PubMed ID: 38162504
[TBL] [Abstract][Full Text] [Related]
18. Identification of lysosomal genes associated with prognosis in lung adenocarcinoma.
Li H; Sha X; Wang W; Huang Z; Zhang P; Liu L; Wang S; Zhou Y; He S; Shi J
Transl Lung Cancer Res; 2023 Jul; 12(7):1477-1495. PubMed ID: 37577321
[TBL] [Abstract][Full Text] [Related]
19. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
[TBL] [Abstract][Full Text] [Related]
20. Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence.
Fu M; Wang Q; Wang H; Dai Y; Wang J; Kang W; Cui Z; Jin X
Front Genet; 2021; 12():639642. PubMed ID: 34490029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
